Levofloxacin 250 MG Oral Tablet — RxCUI 199884
RxNorm drug concept · Semantic clinical drug
RxCUI 199884
Semantic clinical drug · SCD
● Current RxNorm concept 43 FDA products
133 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199884
Official nameLevofloxacin 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevofloxacin (as levofloxacin hemihydrate) 250 MG Oral Tablet
FDA products mapped43
Package NDCs mapped133
Reported Medicaid activity (SDUD)463,106 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levofloxacin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Levofloxacin injection is used when getting the medicine directly into your vein is a better option for you — for example, if you're in the hospital with a serious infection, if yo...
- Why am I getting this antibiotic through an IV instead of a pill?
- The more common side effects are nausea, headache, diarrhea, dizziness, insomnia, and constipation — uncomfortable, but manageable. The ones to take seriously are tendon pain or a...
- What side effects should I watch for and which ones are really serious?
🕸️ Concept Web — How Levofloxacin 250 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levofloxacin 250 MG Oral Tablet
RxCUI 199884 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Levofloxacin
82122IN
-
Levofloxacin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Levaquin
217992BN
-
Levaquin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levofloxacin Oral Tablet
372588SCDF -
Levofloxacin Oral Product
1163467SCDG -
Levofloxacin Pill
1163468SCDG -
Levofloxacin Oral Tablet [Levaquin]
367638SBDF -
Levaquin Oral Product
1167926SBDG -
Levaquin Pill
1167927SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Levofloxacin Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levofloxacin 250 MG
316145SCDC -
Levofloxacin 250 MG Oral Tablet [Levaquin]
211815SBD -
Levofloxacin 250 MG [Levaquin]
572148SBDC
-
Levofloxacin 250 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levofloxacin 250 MG
SCDC · 316145 -
Levofloxacin Oral Tablet
SCDF · 372588 -
Levofloxacin Oral Product
SCDG · 1163467 -
Levofloxacin Pill
SCDG · 1163468
Brand-Name Concepts
-
Levofloxacin 250 MG Oral Tablet [Levaquin]
SBD · 211815 -
Levofloxacin 250 MG [Levaquin]
SBDC · 572148 -
Levofloxacin Oral Tablet [Levaquin]
SBDF · 367638 -
Levaquin Oral Product
SBDG · 1167926 -
Levaquin Pill
SBDG · 1167927 -
Levaquin
BN · 217992
📦 FDA Products & Package NDCs
43 products · 133 package NDCs
133 package NDCs map to RxCUI 199884 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72578-0100-06 | 30 TABLET, FILM COATED in 1 BOTTLE (72578-100-06) | levofloxacin | Viona Pharmaceuticals Inc | 2022-01-10 |
| 72578-0100-18 | 50 TABLET, FILM COATED in 1 BOTTLE (72578-100-18) | levofloxacin | Viona Pharmaceuticals Inc | 2022-01-10 |
| 72578-0100-92 | 20 TABLET, FILM COATED in 1 BOTTLE (72578-100-92) | levofloxacin | Viona Pharmaceuticals Inc | 2022-01-10 |
| 76420-0815-00 | 1000 TABLET, FILM COATED in 1 BOTTLE (76420-815-00) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-05 | 5 TABLET, FILM COATED in 1 BOTTLE (76420-815-05) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-07 | 7 TABLET, FILM COATED in 1 BOTTLE (76420-815-07) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-815-10) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-14 | 14 TABLET, FILM COATED in 1 BOTTLE (76420-815-14) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-815-20) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-815-30) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-50 | 50 TABLET, FILM COATED in 1 BOTTLE (76420-815-50) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-815-60) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0815-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-815-90) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-00 | 1000 TABLET, FILM COATED in 1 BOTTLE (76420-816-00) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-05 | 5 TABLET, FILM COATED in 1 BOTTLE (76420-816-05) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-07 | 7 TABLET, FILM COATED in 1 BOTTLE (76420-816-07) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-816-10) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-14 | 14 TABLET, FILM COATED in 1 BOTTLE (76420-816-14) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-816-20) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-816-30) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-50 | 50 TABLET, FILM COATED in 1 BOTTLE (76420-816-50) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-816-60) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0816-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-816-90) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-05 | 5 TABLET, FILM COATED in 1 BOTTLE (76420-817-05) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-07 | 7 TABLET, FILM COATED in 1 BOTTLE (76420-817-07) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-10 | 10 TABLET, FILM COATED in 1 BOTTLE (76420-817-10) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-14 | 14 TABLET, FILM COATED in 1 BOTTLE (76420-817-14) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-20 | 20 TABLET, FILM COATED in 1 BOTTLE (76420-817-20) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-817-30) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-50 | 50 TABLET, FILM COATED in 1 BOTTLE (76420-817-50) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-55 | 500 TABLET, FILM COATED in 1 BOTTLE (76420-817-55) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-817-60) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
| 76420-0817-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-817-90) | Levofloxacin | Asclemed USA, Inc. | 2024-05-13 |
Observed labelers:
Asclemed USA, Inc. (30) ·
Dr. Reddy's Laboratories Limited (15) ·
Macleods Pharmaceuticals Limited (12) ·
Viona Pharmaceuticals Inc (12) ·
Zydus Lifesciences Limited (12) ·
Aurobindo Pharma Limited (9)
· +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.